155 related articles for article (PubMed ID: 37149966)
1. Identification of the active compounds in the Yi-Fei-San-Jie formula using a comprehensive strategy based on cell extraction/UPLC-MS/MS, network pharmacology, and molecular biology techniques.
Hu L; Luo J; Wen G; Sun L; Liu W; Hu H; Li J; Wang L; Su W; Lin L
Phytomedicine; 2023 Jul; 115():154843. PubMed ID: 37149966
[TBL] [Abstract][Full Text] [Related]
2. A Mechanism Exploration for the Yi-Fei-San-Jie Formula against Non-Small-Cell Lung Cancer Based on UPLC-MS/MS, Network Pharmacology, and
Hu L; He C; Mo A; Zhan X; Yang C; Guo W; Sun L; Su W; Lin L
Evid Based Complement Alternat Med; 2023; 2023():3436814. PubMed ID: 36654811
[TBL] [Abstract][Full Text] [Related]
3. Yi Qi Chu Tan Formula (YQCTF) inhibited the progress of lung cancer via regulating tumor-associated neutrophil: An integrated study of network pharmacology, proteomics and pharmacodynamics.
Le-Xin C; Ming-Jun L; Chun-Qi X; Jia-Xin Z; Jing-Ya Y; Li-Xin N; Mei-Qi W; En-Xin Z; Xiao-Jun Z
J Ethnopharmacol; 2024 Jan; 318(Pt B):116943. PubMed ID: 37532072
[TBL] [Abstract][Full Text] [Related]
4. Reduction in gefitinib resistance mediated by Yi-Fei San-Jie pill in non-small cell lung cancer through regulation of tyrosine metabolism, cell cycle, and the MET/EGFR signaling pathway.
Yang CZ; Guo W; Wang YF; Hu LH; Wang J; Luo JM; Yao XH; Liu S; Tao LT; Sun LL; Lin LZ
J Ethnopharmacol; 2023 Oct; 314():116566. PubMed ID: 37169317
[TBL] [Abstract][Full Text] [Related]
5. The active ingredients and mechanisms of Longchai Jiangxue Formula in treating PV, based on UPLC/Q-TOF-MS/MS, systematic pharmacology, and molecular biology validation.
Ming J; Liu W; Wu H; Li Y; Yang E; Wang Z; Xiao H; Quan R; Hu X
Biomed Pharmacother; 2021 Aug; 140():111767. PubMed ID: 34058439
[TBL] [Abstract][Full Text] [Related]
6. Identifying the active compounds and mechanism of action of Banxia Xiexin decoction for treating ethanol-induced chronic gastritis using network pharmacology combined with UPLC-LTQ-Orbitrap MS.
Ji W; Wang T; Xu Y; An R; Liang K; Wang X
Comput Biol Chem; 2021 Aug; 93():107535. PubMed ID: 34217946
[TBL] [Abstract][Full Text] [Related]
7. The effective compounds and mechanisms of Cang-Fu-Dao-Tan Formula in treating polycystic ovary syndrome based on UPLC/Q-TOF-MS/MS, network pharmacology and molecular experiments.
Hu W; Xie N; Zhu H; Jiang Y; Ding S; Ye S; Zhang S; Wang F; Qu F; Zhou J
J Pharm Biomed Anal; 2024 Feb; 239():115867. PubMed ID: 38061171
[TBL] [Abstract][Full Text] [Related]
8. Discovery of potential quality markers of Fritillariae thunbergii bulbus in pneumonia by combining UPLC-QTOF-MS, network pharmacology, and molecular docking.
Zhou A; Li X; Zou J; Wu L; Cheng B; Wang J
Mol Divers; 2024 Apr; 28(2):787-804. PubMed ID: 36843054
[TBL] [Abstract][Full Text] [Related]
9. Systematically characterized mechanism of treatment for lumbar disc herniation based on Yaobitong capsule ingredient analysis in rat plasma and its network pharmacology strategy by UPLC-MS/MS.
Deng Y; Gao X; Feng T; Wang Z; Xiao W; Xiong Z; Zhao L
J Ethnopharmacol; 2020 Oct; 260():113097. PubMed ID: 32531413
[TBL] [Abstract][Full Text] [Related]
10. Study on the chemical constituents and mechanism of Kai-Xin-San based on UPLC-Q-Exactive MS and network pharmacology.
Shang B; Jia S; Zhang T; Gao F; Lu M; Chen K; Jiao J; Dai Z; Zeng Q; Xu B; Lei H
J Ethnopharmacol; 2024 Mar; 322():117652. PubMed ID: 38151178
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology and LC-MS approachs to explore the active compounds and mechanisms of Yuanjiang decoction for treating bradyarrhythmia.
Wang X; Zhang X; Li J; Fu J; Zhao M; Zhang W; Weng W; Li Q
Comput Biol Med; 2023 Jan; 152():106435. PubMed ID: 36535207
[TBL] [Abstract][Full Text] [Related]
12. Xiao-Luo-Wan treats propylthiouracil-induced goiter with hypothyroidism in rats through the PI3K-AKT/RAS pathways based on UPLC/MS and network pharmacology.
Dong S; Liu Q; Jiang M; Ma Q; Huang Q; Liu T; Li Y; Ni L; Shi Y
J Ethnopharmacol; 2022 May; 289():115045. PubMed ID: 35101570
[TBL] [Abstract][Full Text] [Related]
13. Schisandrol A, the main active ingredient of Schisandrae Chinensis Fructus, inhibits pulmonary fibrosis through suppression of the TGF-β signaling pathway as revealed by UPLC-Q-TOF/MS, network pharmacology and experimental verification.
Wu Z; Jia M; Zhao W; Huang X; Yang X; Chen D; Qiaolongbatu X; Li X; Wu J; Qian F; Lou Y; Fan G
J Ethnopharmacol; 2022 May; 289():115031. PubMed ID: 35091014
[TBL] [Abstract][Full Text] [Related]
14. Identifying the active compounds and mechanism of action of TongFu XieXia Decoction for treating intestinal obstruction using network pharmacology combined with ultra-high performance liquid chromatography-quadrupole-orbitrap mass spectrometry.
Ma L; Wu Y; Luo J; Li F; Zhang M; Cai Y; Dai Y; Pi Z; Zheng F; Yue H
Rapid Commun Mass Spectrom; 2024 Jan; 38(2):e9664. PubMed ID: 38124169
[TBL] [Abstract][Full Text] [Related]
15. A breakthrough in periodontitis treatment: Revealing the pharmacodynamic substances and mechanisms of Kouqiangjie formula.
Wu Y; Liu M; He X; Zhou H; Wei J; Li H; Yuan Q; Zuo Y; Zhao L; Xie Y
J Ethnopharmacol; 2024 Apr; 323():117738. PubMed ID: 38199336
[TBL] [Abstract][Full Text] [Related]
16. Identifying cancer-related molecular targets of Nandina domestica Thunb. by network pharmacology-based analysis in combination with chemical profiling and molecular docking studies.
Taha KF; Khalil M; Abubakr MS; Shawky E
J Ethnopharmacol; 2020 Mar; 249():112413. PubMed ID: 31760157
[TBL] [Abstract][Full Text] [Related]
17. Integrating network pharmacology and transcriptomic validation to investigate the efficacy and mechanism of Mufangji decoction preventing lung cancer.
Gao F; Niu Y; Sun L; Li W; Xia H; Zhang Y; Geng S; Guo Z; Lin H; Du G
J Ethnopharmacol; 2022 Nov; 298():115573. PubMed ID: 35917893
[TBL] [Abstract][Full Text] [Related]
18. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.
Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y
J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367
[TBL] [Abstract][Full Text] [Related]
19. Potential efficacious materials investigation of Yi-Yi Mixture based on Metabolome-oriented network pharmacology strategy.
Gong GW; Tang WH; Zhou Z; Jiang YW; Wang CZ; Cheng H; Cao Y; Jiang ZW
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 May; 1197():123199. PubMed ID: 35305386
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of Bupleurum scorzonerifolium and Paeonia lactiflora herbal pair against liver cancer: an exploration based on UPLC-Q-TOF-MS combined with network pharmacology].
Zou X; Sui Y; Tang XY; Zhang R; Shu Q; Gong T; Wu S; Sun ZW; Li WL; Qu ZY
Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(13):3597-3608. PubMed ID: 35850814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
